Title Thumbnail

Clinical Handbook of Psychotropic Drugs

Ric M. Procyshyn

432 pages
Hogrefe Publishing Corporation

The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals.• Independent, unbiased, up-to-date• Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options• Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug• Potential interactions and side effects summarized in comparison charts• With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek• Clearly written patient information sheets available for download as printable PDF filesThis book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs.

New in this edition:• “Neuroscience-based nomenclature – Pharmacological target/Mode of action” column added to Product Availability Tables (in Antidepressants, Antipsychotics)• Antidepressants chapter includes new section on GABAA Receptor Positive Modulator (Brexanolone IV injection; trade name Zulresso), also updates to SSRIs use in pregnancy and augmentation strategies• Antipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairment• Mood stabilisers chapter sections on Lithium and Anticonvulsants have been extensively revised.• New formulations and trade names include: Caplyta (lumateperine), Dayvigo (Lemborexant), Perseris (risperidone extended-release subcutaneous injection)

Author Bio
Ric M. Procyshyn; BScPharm, MSc, PharmD, PhD; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; British Columbia Mental Health & Addictions Research Institute, Vancouver, BC, Canada